ERIS — Eris Lifesciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapHigh Flyer

Annual balance sheet for Eris Lifesciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	1,421	873	1,504	860	942
Net Total Accounts Receivable
Net Total Receivables	2,108	2,191	2,713	4,593	5,717
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	4,796	4,670	6,273	7,647	23,021
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	873	779	1,919	3,774	5,237
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	15,523	18,348	22,721	36,673	70,488
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1,647	1,669	1,996	4,432	25,321
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	2,560	2,584	3,638	14,713	44,627
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	12,963	15,764	19,083	21,960	25,861
Total Liabilities & Shareholders' Equity	15,523	18,348	22,721	36,673	70,488
Total Common Shares Outstanding